JP2023539614A5 - - Google Patents

Info

Publication number
JP2023539614A5
JP2023539614A5 JP2023513654A JP2023513654A JP2023539614A5 JP 2023539614 A5 JP2023539614 A5 JP 2023539614A5 JP 2023513654 A JP2023513654 A JP 2023513654A JP 2023513654 A JP2023513654 A JP 2023513654A JP 2023539614 A5 JP2023539614 A5 JP 2023539614A5
Authority
JP
Japan
Prior art keywords
methyl
compound
isobutylthiophen
imidazole
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539614A (ja
Filing date
Publication date
Priority claimed from GBGB2013721.2A external-priority patent/GB202013721D0/en
Application filed filed Critical
Publication of JP2023539614A publication Critical patent/JP2023539614A/ja
Publication of JP2023539614A5 publication Critical patent/JP2023539614A5/ja
Priority to JP2026066996A priority Critical patent/JP2026126247A/ja
Pending legal-status Critical Current

Links

JP2023513654A 2020-09-01 2021-09-01 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物 Pending JP2023539614A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026066996A JP2026126247A (ja) 2020-09-01 2026-04-15 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2013721.2 2020-09-01
GBGB2013721.2A GB202013721D0 (en) 2020-09-01 2020-09-01 New compounds
PCT/GB2021/052254 WO2022049372A1 (en) 2020-09-01 2021-09-01 Novel compounds for use in the treatment of diseases associated with angiotensin ii

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026066996A Division JP2026126247A (ja) 2020-09-01 2026-04-15 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物

Publications (2)

Publication Number Publication Date
JP2023539614A JP2023539614A (ja) 2023-09-15
JP2023539614A5 true JP2023539614A5 (cg-RX-API-DMAC7.html) 2024-09-05

Family

ID=72749608

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023513654A Pending JP2023539614A (ja) 2020-09-01 2021-09-01 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物
JP2026066996A Pending JP2026126247A (ja) 2020-09-01 2026-04-15 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026066996A Pending JP2026126247A (ja) 2020-09-01 2026-04-15 アンジオテンシンiiに関連する疾患の治療に使用するための新規化合物

Country Status (13)

Country Link
US (1) US20230348444A1 (cg-RX-API-DMAC7.html)
EP (1) EP4208460A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023539614A (cg-RX-API-DMAC7.html)
KR (1) KR20230058467A (cg-RX-API-DMAC7.html)
CN (1) CN116568682B (cg-RX-API-DMAC7.html)
AU (1) AU2021337193A1 (cg-RX-API-DMAC7.html)
CA (1) CA3189240A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023000580A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023002347A2 (cg-RX-API-DMAC7.html)
GB (1) GB202013721D0 (cg-RX-API-DMAC7.html)
IL (1) IL300582A (cg-RX-API-DMAC7.html)
MX (1) MX2023002522A (cg-RX-API-DMAC7.html)
WO (1) WO2022049372A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202104038D0 (en) * 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
JP2024511453A (ja) * 2021-03-23 2024-03-13 ヴィコール ファルマ アーベー 選択的アンジオテンシンii受容体リガンド
GB202104033D0 (en) * 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
WO2023193733A1 (zh) * 2022-04-06 2023-10-12 武汉人福创新药物研发中心有限公司 一种at2r激动剂
CN120569378A (zh) * 2023-01-09 2025-08-29 维科尔药物公司 选择性血管紧张素ii化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5312820A (en) 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
SE9800550D0 (sv) 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
YU78601A (sh) * 1999-05-05 2005-07-19 Aventis Pharma Deutschland Gmbh. 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
JP4707321B2 (ja) * 2001-05-31 2011-06-22 ヴィコール・ファルマ・アーベー アンギオテンシンiiアゴニストとして有用な三環式化合物
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
AU2003302106A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New tricyclic angiotensin ii agonists
AU2006235698B2 (en) * 2005-04-12 2012-03-29 Vicore Pharma Ab New tricyclic angiotensin II agonists
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
US20170266164A1 (en) 2014-12-12 2017-09-21 Vicore Pharma Ab New methods and uses
WO2016107879A2 (en) 2014-12-30 2016-07-07 Vicore Pharma Ab New use of angiotensin ii receptor agonists
HK1244232A1 (zh) 2015-03-02 2018-08-03 维科尔药物公司 用於治疗肺纤维化的血管紧张素ii受体激动剂
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201710906D0 (en) 2017-07-06 2017-08-23 Vicore Pharma Ab Compounds and methods for treating peripheral neuropathy
GB201913603D0 (en) * 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds

Similar Documents

Publication Publication Date Title
JP2022549086A5 (cg-RX-API-DMAC7.html)
JP2023518948A5 (cg-RX-API-DMAC7.html)
JP2023500437A5 (cg-RX-API-DMAC7.html)
US7351823B2 (en) Preparation process
JP4931893B2 (ja) Ppar活性化化合物及びこれを含有する医薬組成物
RU2332400C2 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
JP2023518474A5 (cg-RX-API-DMAC7.html)
JP2013526494A5 (cg-RX-API-DMAC7.html)
JP2007519692A5 (cg-RX-API-DMAC7.html)
JP2009508963A5 (cg-RX-API-DMAC7.html)
JP2010501587A5 (cg-RX-API-DMAC7.html)
JP2017504576A5 (cg-RX-API-DMAC7.html)
JP2000516593A (ja) 糖尿病及び肥満症の治療に用いられる選択的β▲下3▼作動物質としての置換スルホンアミド
JP2014500322A5 (cg-RX-API-DMAC7.html)
JP2018531218A5 (cg-RX-API-DMAC7.html)
JP2024516033A5 (cg-RX-API-DMAC7.html)
CN1703204A (zh) 含有碱性赋形剂的稳定的药物组合物
JP2007519695A5 (cg-RX-API-DMAC7.html)
JP2019523772A5 (cg-RX-API-DMAC7.html)
JP2019522628A5 (cg-RX-API-DMAC7.html)
JP2024523576A5 (cg-RX-API-DMAC7.html)
JP2003505383A5 (cg-RX-API-DMAC7.html)
CN110156698B (zh) 2-苯基-1,6-二氢嘧啶-5-甲酸衍生物的制备方法和用途
JP5329656B2 (ja) イミダゾリジン誘導体
JP2004532276A5 (cg-RX-API-DMAC7.html)